Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
NSCLC
Interventions
DRUG

Carboplatin

Carboplatin: 2.5 AUC i.v on day 1. Cycle repeated ever 2 weeks

DRUG

Gemcitabine

Gemcitabine: 1100 mg/m2, iv on day 1. Cycle repeated every 2 weeks

Trial Locations (5)

Unknown

University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece, Heraklion

"Laikon General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine", Athens

401 Military Hospital of Athens, Athens

Air Forces Military Hospital of Athens Athens, Greece, Athens

Medical Oncology Unit NIMTS (Veterans Hospital), Athens

All Listed Sponsors
lead

Hellenic Oncology Research Group

OTHER